biotech Archives | Page 2 of 3

Home / Posts tagged biotech (Page 2)

Novotech Opens ChinaTrials 15 Conference with Workshop on how Biotechs can Accelerate Global Trials

SHANGHAI, China, Nov. 07, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, opens the ChinaTrials 15 conference in Shanghai, China with a message to China biotechs about the benefits of conducting simultaneous China, US and Australia trials to accelerate drug development. (November 8-10, 2023) Novotech is commencing this significant summit [...]

Pharmaceutical and Biotech Industry Ventures into Beauty Sector with Emphasis on Healthy Cosmetics

SEOUL, Oct. 30 (Korea Bizwire) – The pharmaceutical and biotechnology industry is making significant strides in enhancing its presence in the beauty sector, particularly in the realm of cosmetics. Industry experts suggest that this strategic shift is aimed at attracting consumers and driving sales by emphasizing pharmaceutical companies’ focus on health. In recent developments, the Yuhan [...]

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]

Pharmaceutical and Biotech Firms Partner to Develop New Drugs Using AI

SEOUL, May 8 (Korea Bizwire) — Pharmaceutical and biotech companies in South Korea are teaming up to develop new drugs using artificial intelligence (AI). During the drug development process, AI can predict whether a chemical compound is suitable for human use, thereby speeding up the identification of potential substances and enabling the selection of appropriate [...]

S. Korean Biotech Firms Increase Nanomedicine-Related Investment and Research Efforts

SEOUL, Aug. 30 (Korea Bizwire) — South Korea’s pharmaceutical and biomedical companies are doubling down on nanomedicine-related investment and research efforts. The Life Science Fund, created jointly by Samsung C&T Corp. and Samsung Biologics Co., decided to invest 19 billion won (US$14 million) in U.S.-based biotech firm Senda Biosciences Inc. last week. Senda possesses the [...]

SK Networks Invests US$12 mln in U.S. Vegan Leather Maker

SEOUL, Jan. 14 (Korea Bizwire) — SK Networks Co., the general trading arm of South Korean conglomerate SK Group, said Friday it has invested US$12 million in a U.S. biotech startup specializing in making alternative leather. SK Networks took part in a round of $126 million funding for MycoWorks, a Silicon Valley-based biomaterials company, and [...]

S. Korea to Spend Over 500 bln Won on Biotech Next Year

SEOUL, Dec. 22 (Korea Bizwire) — South Korea said Tuesday it will invest 520 billion won (US$470 billion) in biotechnology next year as part of efforts to develop treatment and vaccines for COVID-19. The Ministry of Science and ICT said the figure represents a 24.9 percent hike from 2020. The ministry said it will spend [...]

Biotech Firms to Track and Monitor Patients Injected with Stem Cells or Gene Therapy Treatments

SEOUL, July 16 (Korea Bizwire) — New government regulations will require South Korean biotech companies to track and monitor patients who are injected with stem cells or gene therapy treatments. According to the Ministry of Food and Drug Safety on Wednesday, the Advanced Regenerative Bio Act, enacted to strengthen the safety management of advanced regenerative [...]

One Third of Biotech Companies Recorded No Sales Last Year

SEOUL, Jan. 2 (Korea Bizwire) — A recent study has revealed that one third of South Korean biotechnology companies have yet to make a single sale. According to a survey conducted by the Korea Biotechnology Industry Organization, 231 out of 786 biotech companies, or 29.4 percent, were in the pre-sales phase as of 2018. Even [...]

Helsinn Nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association

Switzerland, May 7 (Korea Bizwire) - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that it is one of the companies to have been nominated as one of the Swiss Biotech Association’s Biotech Success Stories for the period 2019/2020. Helsinn was nominated alongside Actelion and Debiopharm, as well as three [...]